Morgan Stanley’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $168M | Sell |
4,190,913
-116,063
| -3% | -$5.49M | 0.01% | 1060 |
|
|
2025
Q4 | $194M | Sell |
4,306,976
-69,749
| -2% | -$3.23M | 0.01% | 958 |
|
|
2025
Q3 | $196M | Buy |
4,376,725
+835,774
| +24% | +$40M | 0.01% | 944 |
|
|
2025
Q2 | $170M | Buy |
3,540,951
+926,671
| +35% | +$40.3M | 0.01% | 958 |
|
|
2025
Q1 | $105M | Sell |
2,614,280
-471,478
| -15% | -$19.8M | 0.01% | 1219 |
|
|
2024
Q4 | $141M | Sell |
3,085,758
-58,470
| -2% | -$2.62M | 0.01% | 1022 |
|
|
2024
Q3 | $147M | Sell |
3,144,228
-202,226
| -6% | -$9.22M | 0.01% | 988 |
|
|
2024
Q2 | $141M | Buy |
3,346,454
+269,895
| +9% | +$11.8M | 0.01% | 968 |
|
|
2024
Q1 | $136M | Sell |
3,076,559
-2,650,395
| -46% | -$121M | 0.01% | 991 |
|
|
2023
Q4 | $264M | Buy |
5,726,954
+2,869,661
| +100% | +$122M | 0.01% | 984 |
|
|
2023
Q3 | $123M | Buy |
2,857,293
+114,256
| +4% | +$5.33M | 0.01% | 946 |
|
|
2023
Q2 | $131M | Sell |
2,743,037
-265,953
| -9% | -$12.8M | 0.01% | 927 |
|
|
2023
Q1 | $147M | Buy |
3,008,990
+263,258
| +10% | +$13.4M | 0.02% | 837 |
|
|
2022
Q4 | $145M | Buy |
2,745,732
+124,935
| +5% | +$6.16M | 0.02% | 821 |
|
|
2022
Q3 | $115M | Buy |
2,620,797
+104,143
| +4% | +$5.14M | 0.02% | 813 |
|
|
2022
Q2 | $126M | Buy |
2,516,654
+1,300,838
| +107% | +$63.5M | 0.02% | 801 |
|
|
2022
Q1 | $63.2M | Buy |
1,215,816
+114,718
| +10% | +$5.92M | 0.01% | 1138 |
|
|
2021
Q4 | $64.9M | Sell |
1,101,098
-157,472
| -13% | -$9.03M | 0.01% | 1179 |
|
|
2021
Q3 | $69M | Buy |
1,258,570
+393,639
| +46% | +$21.9M | 0.01% | 1077 |
|
|
2021
Q2 | $44.4M | Buy |
864,931
+330,648
| +62% | +$17.1M | 0.01% | 1403 |
|
|
2021
Q1 | $27.6M | Sell |
534,283
-350,259
| -40% | -$19.2M | ﹤0.01% | 1627 |
|
|
2020
Q4 | $49.6M | Buy |
884,542
+203,700
| +30% | +$10.9M | 0.01% | 1109 |
|
|
2020
Q3 | $37.7M | Buy |
680,842
+613,094
| +905% | +$31.8M | 0.01% | 1056 |
|
|
2020
Q2 | $3.08M | Sell |
67,748
-22,181
| -25% | -$993K | ﹤0.01% | 3168 |
|
|
2020
Q1 | $3.97M | Sell |
89,929
-299,745
| -77% | -$11.7M | ﹤0.01% | 2673 |
|
|
2019
Q4 | $14M | Sell |
389,674
-422,824
| -52% | -$15.7M | ﹤0.01% | 2032 |
|
|
2019
Q3 | $28.4M | Buy |
812,498
+754,270
| +1,295% | +$29M | 0.01% | 1228 |
|
|
2019
Q2 | $2.5M | Sell |
58,228
-4,531
| -7% | -$188K | ﹤0.01% | 3602 |
|
|
2019
Q1 | $2.71M | Sell |
62,759
-1,004,736
| -94% | -$40.4M | ﹤0.01% | 3331 |
|
|
2018
Q4 | $39M | Sell |
1,067,495
-316,960
| -23% | -$11.8M | 0.01% | 954 |
|
|
2018
Q3 | $55.6M | Buy |
1,384,455
+193,985
| +16% | +$7.75M | 0.01% | 904 |
|
|
2018
Q2 | $45.6M | Buy |
1,190,470
+309,337
| +35% | +$11.4M | 0.01% | 972 |
|
|
2018
Q1 | $30.2M | Sell |
881,133
-726,244
| -45% | -$25.5M | 0.01% | 1295 |
|
|
2017
Q4 | $52.7M | Sell |
1,607,377
-312,338
| -16% | -$10.8M | 0.01% | 919 |
|
|
2017
Q3 | $64.1M | Buy |
1,919,715
+204,602
| +12% | +$7.05M | 0.02% | 772 |
|
|
2017
Q2 | $61M | Buy |
1,715,113
+220,326
| +15% | +$7.44M | 0.02% | 804 |
|
|
2017
Q1 | $45.9M | Buy |
+1,494,787
| New | +$46.1M | 0.01% | 965 |
|
Other funds holding QGEN
VCM
FP
Morgan Stanley's QGEN Position: Q1 2026 in Review
Morgan Stanley reduced its Qiagen (QGEN) stake by 2.7% in Q1 2026, selling an estimated $5.49M and leaving 4,190,913 shares worth $168M. The position accounts for 0.01% of the portfolio, ranked #1060.
Morgan Stanley first reported a position in QGEN in Q1 2017 and has held it in 37 quarters since. The position peaked at $264M in Q4 2023. 343 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.
- Morgan Stanley held 4,190,913 shares of Qiagen worth $168M as of Q1 2026.
- Morgan Stanley sold 116,063 Qiagen shares in Q1 2026, an estimated $5.49M.
- Qiagen made up 0.01% of Morgan Stanley's portfolio in Q1 2026, its #1060 holding.
- Morgan Stanley first reported a position in Qiagen in Q1 2017 and has held it in 37 quarters since.
- Morgan Stanley's Qiagen position peaked at $264M in Q4 2023.
- 343 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.